adenosine monophosphate has been researched along with Embolic Infarction, Posterior Cerebral Artery in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Baysson, H; Beaune, G; Bing, F; Bonardel, C; Bonnerot, M; Chanzy, B; Combes, I; Cornut, L; Farines, M; Ludwig, M; Macheda, G; Vadot, W | 1 |
1 other study(ies) available for adenosine monophosphate and Embolic Infarction, Posterior Cerebral Artery
Article | Year |
---|---|
Bilateral posterior cerebral artery territory infarction in a SARS-Cov-2 infected patient: discussion about an unusual case.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Diagnosis, Differential; Fatal Outcome; Host-Pathogen Interactions; Humans; Infarction, Posterior Cerebral Artery; Male; Middle Aged; Pandemics; Pneumonia, Viral; Predictive Value of Tests; Risk Factors; SARS-CoV-2; Thrombolytic Therapy; Treatment Outcome | 2020 |